Blood type is written into your DNA, inherited from your parents, and under normal circumstances it stays the same from birth to death. But “under normal circumstances” is doing a lot of work in that sentence. There are real, documented situations in which a person’s blood type genuinely changes, and other situations where it only appears to change because something is interfering with how it gets detected. The distinction matters, especially if you ever need a transfusion or organ transplant.
What Determines Your Blood Type in the First Place
Your ABO blood type depends on which sugar molecules sit on the surface of your red blood cells. The genes you inherit code for enzymes called glycosyltransferases, which attach specific sugars to a precursor chain on each red cell’s surface.1FEMS Microbiology Immunology. The ABO, Lewis and related blood group antigens; a review of structure and biosynthesis If you inherited the gene for the A enzyme, your cells wear the A sugar and you’re type A. Inherited the B enzyme gene, you’re type B. Got both, you’re AB. Got neither functional version, nothing extra gets added, and you’re type O. The Rh factor (the “positive” or “negative” part) works differently — it’s a protein on the red cell surface rather than a sugar — but it’s also genetically determined.
Because the instructions live in the DNA of your blood-forming stem cells deep in your bone marrow, every new red blood cell your body churns out carries the same surface markers. Your body makes roughly two million new red cells every second, and each one faithfully displays whatever antigens your genes dictate. That’s why blood type is considered permanent. To change it, you’d have to change what’s happening inside the stem cells themselves — or replace them entirely.
Bone Marrow and Stem Cell Transplants
The clearest and most permanent way someone’s blood type can change is through a bone marrow or hematopoietic stem cell transplant. When a patient’s diseased bone marrow is destroyed (usually with high-dose chemotherapy or radiation) and replaced with donor stem cells, those donor cells become the new factory for all blood cells. If the donor has a different blood type than the recipient, the patient’s blood type gradually shifts to match the donor’s.
This transition doesn’t happen overnight. For weeks or even months, both the old and new blood types can coexist in the patient’s body as remaining old red cells die off and new donor-derived cells take over. Eventually, the conversion is complete — the patient truly has a new blood type. A case report described a patient who received stem cells from a type A donor while originally being type B. After some time, the patient reverted to his original blood group B, which created problems when he later needed a kidney transplant that had been matched to his post-transplant type A status.2Europe PMC. Temporal Change in Blood Group after Bone Marrow Transplant: A Case of Successful ABO-Incompatible Deceased Donor Transplant That kind of reversion is rare, but it highlights why transplant teams keep retesting blood type rather than relying on older records.
For patients who undergo ABO-incompatible transplants (where the donor’s blood type doesn’t match their own), the medical team typically needs to manage a transitional period carefully to avoid immune reactions against the incoming or outgoing red cells. But if the transplant engrafts successfully, the blood type change is real and lasting.
Leukemia and Other Blood Cancers
Certain blood cancers can cause what looks like a blood type change, though the mechanism is different from a transplant. In acute myeloid leukemia (AML), malignant cells can suppress the normal production of blood group antigens. Patients who previously typed as A, B, or AB have shown weakened or absent antigen expression during the active phase of their disease. When these patients achieved remission, their original blood group antigens reappeared.3PubMed Central. Blood group change in acute myeloid leukemia
This isn’t a permanent change — it’s more like the leukemia is temporarily scrambling the machinery that decorates red cells with the right sugars. But in a clinical setting, a patient whose blood type seems different from what’s on file can create real confusion in the blood bank. Lab staff may flag it as a clerical error when it’s actually a sign of the disease itself.
Organ Transplants and Passenger Lymphocyte Syndrome
You don’t need a bone marrow transplant for transplant-related blood type complications. Solid organ transplants — liver, kidney, heart, lung — can cause a transient immune reaction called passenger lymphocyte syndrome (PLS). When an organ is transplanted, it carries along some of the donor’s immune cells (the “passengers”). If the donor’s and recipient’s blood types don’t match perfectly, those hitchhiking immune cells can start producing antibodies against the recipient’s own red blood cells.4PubMed Central. Passenger lymphocyte syndrome – Epidemiology, pathogenesis, diagnosis, treatment and future directions: A review
PLS doesn’t change your blood type in the genetic sense — your own bone marrow keeps making the same cells it always did. But the donor-derived antibodies can destroy enough of your red blood cells to cause clinically significant anemia, sometimes requiring transfusion. It’s most common in minor ABO and Rh mismatched transplants, and liver transplants carry a higher risk because the liver is packed with immune tissue.5PubMed Central. Passenger lymphocyte syndrome in liver transplant recipients: a description of 12 cases The syndrome is usually self-limiting — the donor’s immune cells eventually die off — but during the active phase, serological testing can give confusing results that mimic a blood type change.6Blood. Passenger Lymphocyte Syndrome Following Solid Organ Transplantation: Graft Source, Incidence, Specificity, Duration, and Severity Of Hemolysis
Bacterial Infections and the “Acquired B” Phenomenon
One of the stranger ways blood type can appear to change involves gut bacteria. In certain infections, especially those involving gram-negative bacteria in the colon or urinary tract, bacterial enzymes can chemically modify the A antigen on red blood cells so that it starts to resemble the B antigen. A patient who has always been type A suddenly seems to test as type AB or even type B.
This “acquired B” phenomenon is well documented in the transfusion medicine literature. The bacterial enzyme deacetylates the terminal sugar on the A antigen, creating a structure that cross-reacts with anti-B testing reagents. It’s not a genetic change at all — the patient’s DNA still codes for type A. And once the infection is treated, the false B reactivity disappears. The phenomenon is rare but clinically relevant because transfusing type B or AB blood into someone who is actually type A could trigger a serious transfusion reaction.
Autoimmune Conditions That Scramble Testing
Autoimmune hemolytic anemia (AIHA) is another condition that can make blood type testing unreliable without actually altering the underlying genetics. In AIHA, the immune system produces antibodies that attack the patient’s own red blood cells. When both warm-reacting and cold-reacting autoantibodies are present (mixed-type AIHA), the resulting interference can cause blood group discrepancies or make cross-matching nearly impossible.7PubMed Central. Blood group discrepancy in mixed-type autoimmune hemolytic anemia in a pediatric patient
In at least one reported case, autoantibodies mimicking anti-D (the Rh factor antibody) caused a patient’s Rh type to be misidentified — a potentially dangerous error when it comes to transfusion decisions.8PubMed. Faulty blood typing misled by auto anti-D in AIHA Again, the patient’s actual blood type hasn’t changed. But from the perspective of the lab technician running the tests, the results look wrong, and resolving the discrepancy takes specialized techniques.
Does Aging Affect Your Blood Type?
Your blood type genes don’t change as you get older, but the strength of your immune system’s response to blood type antigens does. A study comparing ABO antibody titers in elderly patients versus young adults found that older individuals had roughly tenfold lower antibody levels across all blood groups. Where a young adult might show a titer of 64, an elderly person typically showed a titer of around 6, with weaker agglutination reactions overall.9Majalah Kedokteran Bandung. Comparison of ABO Blood Group Antibody Titers in Elderly and Young Adult Patients
This matters because standard blood typing relies partly on detecting these antibodies (the “reverse typing” step, where the lab checks which antibodies are floating in your serum). With weaker antibodies in older patients, the reverse typing may give ambiguous results, which can look like a discrepancy with the forward type. It’s not a blood type change — it’s an aging immune system producing less of what the test expects to see. Blood bank technicians working with elderly patients need to be aware that low antibody titers can complicate routine typing.
Chimerism and the People With Two Blood Types at Once
Some people are born with two genetically distinct cell populations in their body, a condition called chimerism. The most dramatic form, tetragametic chimerism, arises when two fraternal twin embryos fuse very early in development. The resulting individual is a single person carrying two complete sets of DNA. In one reported case, a four-year-old boy typed as AB, but the agglutination pattern was unusual. Molecular analysis revealed that his white blood cells carried two separate ABO genotypes — one inherited as A/O and the other as B/O — meaning he was literally two people’s worth of genetic information merged into one body.10PubMed. Congenital tetragametic blood chimerism explains a case of questionable paternity
Chimeric individuals don’t experience a blood type “change” — they’ve had both cell populations from conception. But chimerism often goes undetected until a blood test returns baffling results, sometimes decades into someone’s life. These cases can also complicate paternity testing and forensic identification, since different tissues may yield different genetic profiles.
Microchimerism From Pregnancy
A milder and far more common version of chimerism happens during pregnancy. Fetal cells cross the placenta into the mother’s bloodstream starting as early as the fourth to sixth week of gestation, and the traffic increases as pregnancy progresses. Most of these cells are cleared by the mother’s immune system in the weeks after delivery, but a small fraction can persist in maternal tissues for decades.11PubMed Central. Feto-maternal microchimerism: Memories from pregnancy
This feto-maternal microchimerism rarely affects blood typing in any practical way — the number of fetal cells is tiny compared to the mother’s own blood cell production. But it’s a fascinating reminder that biological boundaries between individuals are fuzzier than we tend to assume. Traffic goes both ways, too: maternal cells are found in children’s tissues well after birth. Whether this microchimerism has health consequences (good or bad) is an active area of research.
The Rh Factor Isn’t Always Clear-Cut
Most people think of Rh status as a simple binary: you’re either positive or negative. The reality is messier. The D antigen (the protein responsible for “Rh positive” status) has numerous genetic variants that produce weaker or altered versions of the protein. People with these “weak D” or “partial D” variants may test differently depending on which testing reagent is used, which lab performs the test, or even how the sample is handled.12PubMed Central. A simple diagnostic strategy for RhD typing in discrepant cases in the Indian population
A person with a weak D variant might test as Rh-positive at one hospital and Rh-negative at another, or get different results on different days. This isn’t a blood type change — it’s a limitation of serological testing when the underlying biology falls in a gray zone. Molecular genotyping, which looks at the DNA directly rather than the protein on the cell surface, can resolve these discrepancies.13PubMed. A multi-centre study on the performance of the molecular genotyping platform ID RHD XT for resolving serological weak RhD phenotype in routine clinical practice For clinical decisions about pregnancy management (Rh-negative mothers receiving anti-D immunoglobulin, for example), knowing whether someone is truly Rh-negative versus carrying a weak D variant can matter.
The Bombay Phenotype and Genetic Masking
There’s an even rarer genetic situation where someone appears to be type O on standard testing but actually carries functional A or B genes. This is the Bombay phenotype, caused by mutations in the FUT1 gene. Normally, the FUT1 gene produces an enzyme that builds the H antigen — the precursor structure onto which the A and B sugars are added. Without a working H antigen, the A and B enzymes have nothing to modify, so neither A nor B sugars appear on the red cells. Standard testing reads this as type O.14PubMed Central. FUT1 mutations responsible for the H-deficient phenotype in the Polish population, including the first example of an abolished start codon
People with the Bombay phenotype can run into serious problems if transfused with regular type O blood, because even type O blood carries the H antigen, and Bombay individuals produce antibodies against it. Their blood type hasn’t changed — it was always masked — but a standard test would never reveal the underlying genetics. Only specialized testing uncovers the true picture.
The Cis-AB Curiosity
Another genetic oddity that can look like something has gone wrong with blood typing is the cis-AB phenotype. Normally, you inherit one ABO allele from each parent. But in cis-AB, a single allele inherited from one parent codes for an enzyme capable of producing both A and B antigens.15PubMed Central. Cis-AB, the Blood Group of Many Faces, Is a Conundrum to the Novice Eye This creates inheritance patterns that seem to break the rules — like a type AB mother having a type O child, which standard genetics would say is impossible.16PubMed. The cis-AB blood group phenotype: fundamental lessons in glycobiology
Cis-AB individuals don’t experience a blood type change either, but their unusual genetics can make it look like someone’s blood type results don’t add up, especially in family studies or paternity cases. The mutant enzyme involved typically produces weaker-than-normal A or B antigens, which adds to the diagnostic confusion.
Laboratory Efforts to Convert Blood Types
If blood type depends on surface sugars, could you strip those sugars off and effectively convert any blood to type O? Researchers have been working on exactly this idea for decades, and the progress is real. The concept is straightforward: use an enzyme (a glycosidase) to clip off the A or B sugar from red blood cells, leaving behind the universal-donor O type.17PubMed Central. Toward universal donor blood: Enzymatic conversion of A and B to O type
One research team expressed an enzyme in yeast that successfully converted group A red blood cells to type O. The treated cells no longer reacted with anti-A antibodies or with serum from type B and type O individuals.18PubMed Central. Production of Universal Group O Red Blood Cells by Alpha-N-Acetylgalactosaminidase Enzyme Expressed in Pichia pastoris The challenge has always been efficiency: early enzymes required impractical quantities to convert a useful amount of blood. Newer enzymes sourced from gut bacteria are far more efficient, bringing the concept closer to clinical feasibility, though no enzymatic conversion product has reached routine clinical use yet.
Meanwhile, gene editing is pushing the boundaries further. Researchers have used CRISPR to knock out the ABO gene in stem cells derived from a type A donor, converting them to type O at the genetic level.19PubMed Central. ABO gene editing for the conversion of blood type A to universal type O in Rhnull donor-derived human-induced pluripotent stem cells Another group achieved near-complete conversion of both ABO and Rh antigens using CRISPR on blood-forming stem cells, producing red blood cells that tested as O-negative.20Human Molecular Genetics. CRISPR-Cas9-driven antigen conversion of clinically relevant blood group systems These are laboratory-stage achievements, not therapies, but they demonstrate that permanent blood type conversion is at least technically possible with the right tools.
Why Blood Type Diversity Persists
If type O blood is universally compatible for donations, you might wonder why evolution hasn’t pushed everyone toward type O. Part of the answer involves infectious disease. Research has shown that type O blood offers some protection against severe malaria caused by Plasmodium falciparum, the deadliest malaria parasite, through a mechanism involving reduced clumping of infected red blood cells.21PubMed Central. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting The geographic distribution of type O tracks with areas where malaria has been historically intense, consistent with selection pressure favoring O in those regions.22PubMed. The ABO blood group system and Plasmodium falciparum malaria
But type O isn’t universally advantageous. It’s been associated with higher susceptibility to certain other pathogens, and types A and B may carry their own protective advantages against different diseases. This balancing act — where no single blood type wins in every environment — is likely why all the major types persist in the human population rather than being winnowed down to one.
Cross-Species Blood Type Barriers
The surface antigens that define blood type are also central to one of the biggest challenges in xenotransplantation, the transplanting of animal organs into humans. Pig cells carry a sugar called galactose-alpha-1,3-galactose (Gal for short) that humans don’t produce. Human immune systems have preformed antibodies against Gal, which means a transplanted pig organ triggers an explosive immune reaction — hyperacute rejection — within minutes to hours.23PubMed Central. Immunobiological barriers to xenotransplantation Modern approaches to pig-to-human transplantation involve genetically engineering pigs to knock out the Gal antigen (and other incompatible surface molecules), essentially changing the pig’s “blood type” at the genetic level before the organ is ever harvested. It’s the same principle as the CRISPR work on human stem cells, applied across species.